Everett BM, Zeller T, Glynn RJ, Ridker PM, Blankenberg S.Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Blankenberg S, Salomaa V, Makarova N, et al.High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. ![]() 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Piepoli MF, Hoes AW, Agewall S, et al.Relative prognostic value of cardiac troponin I and C-reactive protein in the general population (from the Nord-Trøndelag Health Study). Sigurdardottir FD, Lyngbakken MN, Holmen OL, et al.Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. DeFilippis AP, Young R, Carrubba CJ et al. ![]() Lake Bluff, IL: Abbott Laboratories 2019. Lake Bluff, IL: Abbott Laboratories 2018.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |